Target intelligence / Profile preview

Gap junction alpha-1 protein mRNA (Cx43 mRNA) (Cx43 mRNA)

Target
Cx43 mRNA
Molecular classification
Nucleic acid, Messenger RNA
01

Overview

Gap junction alpha-1 protein (Cx43) mRNA is the transcript of the GJA1 gene, encoding the most prevalent gap junction protein in the human body (UniProt P17302). Cx43 is essential for forming intercellular channels that allow the passage of ions and small metabolites, playing a vital role in cardiac conduction and skin wound healing (PubMed: 19435111). In chronic wounds, such as diabetic foot ulcers, Cx43 mRNA and protein are often overexpressed at the wound edge, which inhibits cell migration and promotes inflammation (PubMed: 24511355). Therapeutic targeting of Cx43 mRNA using antisense oligonucleotides (ASOs), like Nexagon (CODA-001), aims to transiently downregulate protein expression to accelerate re-epithelialization and reduce scarring (ClinicalTrials.gov: NCT00820144). This approach leverages the temporary knockdown of the protein to shift the wound environment from a chronic inflammatory state to a regenerative one.

Other names
GJA1 mRNAConnexin-43 mRNAGap junction protein alpha 1 mRNA
02

Mechanism of action

Antisense inhibition of translation via sequence-specific binding to mRNA transcripts, leading to reduced protein synthesis (PubMed: 19435111).

03

Biological functions

Translation template for Connexin 43 proteinRegulation of intercellular communicationWound healing modulationInflammatory response regulation
04

Disease associations

Diabetic foot ulcerVenous leg ulcerCorneal epithelial defectChronic inflammationOcular surface disease
05

Safety considerations

Local administration site reactionsPotential off-target hybridizationTheoretical cardiac conduction interference if systemic exposure occurs (PubMed: 24511355)
06

Interacting drugs

Nexagon

1 more in the full profile.

07

Biomarkers

Connexin 43 protein expression levelsGJA1 mRNA expression levelsWound closure rate

Beyond the preview

Go deeper on Gap junction alpha-1 protein mRNA (Cx43 mRNA) (Cx43 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gap junction alpha-1 protein mRNA (Cx43 mRNA) (Cx43 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call